Y-mAbs Therapeutics Stock (NASDAQ: YMAB) stock price, news, charts, stock research, profile.
Open | $13.88 |
Close | $13.06 |
Volume / Avg. | 183.82K / 294.07K |
Day Range | $12.88 - $13.88 |
52 Wk Range | 4.69 - 20.90 |
Market Cap | $582.08M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 47 |
Short Interest | 11.29% |
Days to Cover | 11.91 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Y-mAbs Therapeutics (NASDAQ:YMAB) through any online brokerage.
Other companies in Y-mAbs Therapeutics’s space includes: Humacyte (NASDAQ:HUMA), 4D Molecular Therapeutics (NASDAQ:FDMT), Celcuity (NASDAQ:CELC), Altimmune (NASDAQ:ALT) and Opthea (NASDAQ:OPT).
Y-mAbs Therapeutics has a consensus price target of $19.17.
The stock price for Y-mAbs Therapeutics (NASDAQ: YMAB) is $13.06 last updated September 23, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Y-mAbs Therapeutics.
Y-mAbs Therapeutics’s Q3 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for Y-mAbs Therapeutics.
Y-mAbs Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.